TAYSHA GENE THERAPIES INC (TSHA) Institutional Ownership Changes & 13F Activity
TAYSHA GENE THERAPIES INC (TSHA). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings. This page analyzes institutional buying and selling activity, new holdings, and sold-out positions among tracked filers. Notable filers include Renaissance Technologies LLC and Polen Capital Management.
| Portfolio quarter | Name | Type | Quantity | Remaining | Reported stock balance |
|---|---|---|---|---|---|
| Q1 2026 | Renaissance Technologies LLC | Buy | 242,103 | 413,203 | $1,847,017 |
| Q1 2026 | Polen Capital Management | Buy | 163,162 | 319,748 | $1,429,274 |
| Q4 2025 | Polen Capital Management | Buy | 156,586 | 156,586 | $861,223 |
| Q4 2025 | Renaissance Technologies LLC | Buy | 116,200 | 171,100 | $941,050 |
| Q2 2025 | Renaissance Technologies LLC | Sell | -823,548 | 54,900 | $126,819 |
| Q4 2024 | Renaissance Technologies LLC | Buy | 837,348 | 878,448 | $1,519,715 |
| Q2 2024 | Renaissance Technologies LLC | Sell | -287,400 | 41,100 | $92,064 |
| Q1 2024 | Renaissance Technologies LLC | Sell | -768,900 | 328,500 | $943 |
| Q4 2023 | Renaissance Technologies LLC | Buy | 499,400 | 1,097,400 | $1,942 |
| Q3 2023 | Renaissance Technologies LLC | Buy | 373,600 | 598,000 | $1,890 |
| Q2 2023 | Renaissance Technologies LLC | Sell | -25,200 | 224,400 | $148 |
| Q1 2023 | Renaissance Technologies LLC | Sell | -270,200 | 249,600 | $199 |
| Q4 2022 | Renaissance Technologies LLC | Buy | 101,300 | 519,800 | $1,175 |
| Q3 2022 | Renaissance Technologies LLC | Sell | -105,100 | 418,500 | $808 |
| Q2 2022 | Renaissance Technologies LLC | Buy | 273,100 | 523,600 | $1,948 |
| Q1 2022 | Renaissance Technologies LLC | Buy | 250,500 | 250,500 | $1,633 |
Frequently asked questions about TSHA activity
Which institutional owners are buying TSHA?
Institutional owners buying TSHA include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in TSHA activity?
"Buy" means an investor increased their reported position in TSHA compared to the prior reporting period. This reflects growing exposure to TAYSHA GENE THERAPIES INC (TSHA) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in TSHA increasing?
Institutional interest in TSHA can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related TSHA Institutional Insights
- TSHA Institutional Ownership Overview
- TSHA Institutional Ownership & Insiders Activity
- TSHA Institutional Ownership & 13F Activity
- TSHA Top Institutional Shareholders
- TSHA Institutional Buying Activity
- TSHA Institutional Selling Activity
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- TSHA Insider Trading & SEC Form 4 Activity
- Top Institutional Investor Stock Rankings